Location History:
- Gentilly, FR (2021)
- Paris, FR (2021)
Company Filing History:
2 out of 154 
2 out of 1,744 
Years Active: 2021
Title: The Innovative Journey of Elodie Manie
Introduction
Elodie Manie, a brilliant inventor based in Gentilly, France, has made significant strides in the field of genetics and oncology. With two patents to her name, her work primarily focuses on the detection and understanding of inactivation pathways crucial for patient diagnostics.
Latest Patents
Elodie Manie has developed two notable patents, both centered around methods for detecting the inactivation of the homologous recombination pathway, particularly concerning BRCA1 and BRCA2 genes in human tumors. These patents provide insightful methodologies for identifying DNA homologous recombination pathway inactivation in patients, presenting vital diagnostic tools that could influence treatment strategies significantly.
Career Highlights
Throughout her career, Elodie has contributed to esteemed institutions such as Institut Curie and the Institut National de la Santé et de la Recherche Médicale. Her tenure at these prominent research establishments showcases her commitment to advancing medical research and innovation.
Collaborations
Elodie Manie's collaboration with distinguished colleagues, including Marc-Henri Stern and Tatiana Popova, highlights her ability to work within multidisciplinary teams dedicated to pioneering research and solutions in genetics and oncology.
Conclusion
Elodie Manie's contributions to the field of genetic research and her innovative patents position her as a noteworthy inventor in the realm of human health. Her work has the potential to advance medical diagnostics and personalize treatment approaches for cancer patients dealing with BRCA1 and BRCA2 inactivation.